Investors

The share

December 3rd 2021, 6:00:00 pm +/- % Buy Sell Last High Low Volume
ENZY (Stockholm) SEK/share - -0.99% 8.84 9.01 9.01 9.10 8.30 448932

Share capital

At the end of 2020, the share capital of Enzymatica AB was SEK 5,712,950 SEK, distributed among 142,823,696 shares, each with a par value of SEK 0.04.

The Company has only one class of stock. Each share entitles the holder to one vote at Enzymatica’s general meeting of shareholders. Each shareholder who is entitled to vote may vote at the general meeting for the full number of shares that he or she owns and represents. Each share carries equal rights to a part of the Company’s assets and profit.

Dividend

The Board of Directors does not intend to propose any dividend until the Company generates a profit and a positive cash flow.

Ownership structure

The number of shareholders at year-end was 9,596, an increase with approx. 237 % compared to 2019.

Name

Number of shares

Percentage of capital and votes (%)

Mats Andersson, privately and through Abanico Invest AB

31 081 437

20,8%

Håkan Roos, through Roosgruppen AB

19 029 461

12,7%

Björn Algkvist through Fibonacci Asset Management

16 227 416

10,9%

Gudmundur Palmason, through Fortus hf company

7 746 27

5,2%

Ágústa Gudmundsdottir, privately and through company

5 190 79

3,5%

Aktiebolaget Possessor

3 700 000

2,5%

Avanza Pension Försäkring AB

3 078 607

2,1%

Nordnet Pensionsförsäkring AB

3 205 067

2,1%

Ulf Wiinberg, privately and through company

1 968 657

1,3%

Bengt Baron, privately and through company

1 812 496

1,2%

Holdings 10 largest shareholders

93 007 277

62,3%

Other

56 317 123

37,7%

Total

149 324 400

100,0%

Euroclear 30 September 2021

Analyses

During the year Enzymatica was analyzed by ABG Sundal Collier and Erik Penser Bank.

Rickard Anderkrans ABG Sundal Collier: rickard.anderkrans@abgsc.se

Johan Löchen, Penser: johan.lochen@penser.se